Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Annales De Genetique
|
January 1, 1989
Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemia
J L Huret, H Mossafa, A Brizard, et al.
Mutation Research
|
July 1, 1994
Checks for chromosomal instability in Gorlin and non-Gorlin basal-cell carcinoma patients
E Shafei-Benaissa, J L Huret, M Larrègue, et al.
Human Genetics
|
March 1, 1987
Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality
J L Huret, J M Delabar, F Marlhens, et al.
Cancer
|
August 15, 1983
Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors
H Castro-Malaspina, G Schaison, J Briere, et al.
Ophthalmology. Retina
|
October 2, 2020
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment
Caroline R Baumal, Bahram Bodaghi, Michael Singer, et al.
Ophthalmology
|
November 4, 2009
Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology
David Huang, Steven C Schallhorn, Alan Sugar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1985
Agar human T cell colony growth promoted by a B + null cell-derived lymphokine distinct from IL 2
M D Mossalayi, P G de Laforest, F Guilhot, et al.
British Journal of Haematology
|
December 1, 1992
Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy
M C Malinge, F X Mahon, M H Delfau, et al.
British Journal of Haematology
|
February 1, 1993
Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon
A Meseri, V Delwail, A Brizard, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study
David S Boyer, Peter K Kaiser, George N Magrath, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Annales De Genetique
|
January 1, 1989
Karyotypes of 33 patients with clonal aberrations in chronic lymphocytic leukaemia. Review of 216 abnormal karyotypes in chronic lymphocytic leukaemia
J L Huret, H Mossafa, A Brizard, et al.
Mutation Research
|
July 1, 1994
Checks for chromosomal instability in Gorlin and non-Gorlin basal-cell carcinoma patients
E Shafei-Benaissa, J L Huret, M Larrègue, et al.
Human Genetics
|
March 1, 1987
Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality
J L Huret, J M Delabar, F Marlhens, et al.
Cancer
|
August 15, 1983
Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic factors
H Castro-Malaspina, G Schaison, J Briere, et al.
Ophthalmology. Retina
|
October 2, 2020
Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment
Caroline R Baumal, Bahram Bodaghi, Michael Singer, et al.
Ophthalmology
|
November 4, 2009
Phakic intraocular lens implantation for the correction of myopia: a report by the American Academy of Ophthalmology
David Huang, Steven C Schallhorn, Alan Sugar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 1, 1985
Agar human T cell colony growth promoted by a B + null cell-derived lymphokine distinct from IL 2
M D Mossalayi, P G de Laforest, F Guilhot, et al.
British Journal of Haematology
|
December 1, 1992
Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy
M C Malinge, F X Mahon, M H Delfau, et al.
British Journal of Haematology
|
February 1, 1993
Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon
A Meseri, V Delwail, A Brizard, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
October 14, 2022
The Safety and Biological Activity of OTT166, a Novel Topical Selective Integrin Inhibitor for the Treatment of Diabetic Eye Disease: A Phase 1b Study
David S Boyer, Peter K Kaiser, George N Magrath, et al.
Page
of 11